FDA Inspection
Peter Stacpoole, M.D.Peter Stacpoole, M.D. – FDA Inspection, Jun 15, 2017
Record Details
This FDA Inspection record concerns Peter Stacpoole, M.D., with an inspection on June 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ce27bc64-25b1-44ca-a3d8-9d4e3981358d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1014219
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.50Ensuring compliance with plan and protocol
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.20Circumstances of obtaining consent
- 21 CFR 312.62(a)Unused drug disposition (investigator)
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.